Colorado Health Reporter
SEE OTHER BRANDS

Your health and wellness news from Colorado

Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

Press releases published on July 30, 2025

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year  Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06, Respectively Second Quarter Adjusted EBITDA was $24 …

 Prime Medicine Announces Proposed Public Offering of Common Stock

Prime Medicine Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an …

Why Value-Based Care in the U.S. Is Still Stuck in First Gear

Why Value-Based Care in the U.S. Is Still Stuck in First Gear

Winston-Salem, NC, July 30, 2025 (GLOBE NEWSWIRE) -- America’s health care system is facing a reckoning. Costs are climbing. The population is aging. Workforce shortages persist. Health disparities are widening. These pressures are pushing providers, …

Sharecare to collaborate with Centers for Medicare & Medicaid Services to improve care quality, accelerate progress in healthcare

Sharecare to collaborate with Centers for Medicare & Medicaid Services to improve care quality, accelerate progress in healthcare

ATLANTA and WASHINGTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced it is among the early adopters  …

Human Microbiome Market to Grow at 25.6% CAGR Through 2030

Human Microbiome Market to Grow at 25.6% CAGR Through 2030

Boston, July 30, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Human Microbiome-based Drugs and Diagnostics: Global Markets” is expected to grow from $393.4 million in 2025 to $1.2 billion by the end of 2030, at a compound …

KSHE Summer Blood Drive draws 2158 donors

KSHE Summer Blood Drive draws 2158 donors

Earth City, Missouri, July 30, 2025 (GLOBE NEWSWIRE) -- During some of the most challenging weeks of summer, ImpactLife turns to fans of “real rock radio” KSHE-95 for help with the St. Louis region’s blood supply. The loyal and generous KSHE audience came …

Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight

Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight

New York, USA, July 30, 2025 (GLOBE NEWSWIRE) -- Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight The amniotic membrane market is experiencing notable expansion, fueled by several contributing factors. …

Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision

Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision

WARREN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the Company’s significant insider ownership of outstanding common stock, as most recently reported on July 10, 2025, on …

The Slaight Family Foundation announces Red Cross as part of its emergency support funding

The Slaight Family Foundation announces Red Cross as part of its emergency support funding

OTTAWA, Ontario, July 30, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross extends its gratitude to Gary Slaight and The Slaight Family Foundation for a $1 million contribution over two years, in support of humanitarian efforts in Cox’s Bazar, Bangladesh. …

Optometrist Dr. Selina McGee Highlights the Dry Eye Epidemic and New Skincare Solutions with YourUpdateTV

Optometrist Dr. Selina McGee Highlights the Dry Eye Epidemic and New Skincare Solutions with YourUpdateTV

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Dry eye disease affects millions and is increasingly driven by prolonged screen time, dry indoor environments, and everyday beauty products that can inadvertently irritate or damage the eyes. Nearly half of …

SupplyCopia to Showcase Enhanced AI Healthcare Solutions at AHRMM25

SupplyCopia to Showcase Enhanced AI Healthcare Solutions at AHRMM25

BRIDGEWATER, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- SupplyCopia, a leader in AI-driven healthcare supply chain transformation, announces its participation at the upcoming AHRMM Conference in Denver, Colorado, from August 3-6. The company will demonstrate …

Explore Healthcare Career Paths at Carrington College Open House

Explore Healthcare Career Paths at Carrington College Open House

SACRAMENTO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Carrington College campuses will host an Open House on Thursday, Aug. 14, from 10 a.m. to 7 p.m., inviting prospective students and community members to explore its programs in medical, dental, …

FDA Provides Trethera Clearance to Initiate TRE-515 Clinical Trial in Healthy Volunteers to Study Food Effect and Biomarkers

FDA Provides Trethera Clearance to Initiate TRE-515 Clinical Trial in Healthy Volunteers to Study Food Effect and Biomarkers

LOS ANGELES, July 30, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that the U.S. Food and Drug Administration …

BrainsWay Champions TMS Education with Sponsorship of Two Free CME Courses for Mental Health Professionals

BrainsWay Champions TMS Education with Sponsorship of Two Free CME Courses for Mental Health Professionals

BURLINGTON, Mass. and JERUSALEM, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay, a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, is proud to announce its underwriting of two new Continuing Medical …

Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™.

Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™.

Delray Beach, FL, July 30, 2025 (GLOBE NEWSWIRE) -- The global Advanced Wound Care Market, valued at US$12.48 billion in 2024 stood at US$13.37 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a …

Life Backup Plan by Galacxia, Inc Announces $45K in Funding to Expand Its AI-Powered Health and Safety App

Life Backup Plan by Galacxia, Inc Announces $45K in Funding to Expand Its AI-Powered Health and Safety App

Aliso Viejo, CA, July 30, 2025 (GLOBE NEWSWIRE) -- Life Backup Plan by Galacxia, Inc, redefining how individuals and care systems manage everything from emergencies to healthcare communication, today announced $45,000 in new funding. The investment will …

Registration Now Open for the 2026 MDA Clinical & Scientific Conference Where Global Leaders in Neuromuscular Disease Research & Care Unite to Drive the Next Breakthroughs March 8-11 in Orlando, FL

Registration Now Open for the 2026 MDA Clinical & Scientific Conference Where Global Leaders in Neuromuscular Disease Research & Care Unite to Drive the Next Breakthroughs March 8-11 in Orlando, FL

New York, July 30, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA), leader and innovator of the largest global gathering of the neuromuscular disease community, announced today that registration is open for the 2026 MDA Clinical …

Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1

Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1

- ABO-101 was well tolerated with no serious adverse events or dose-limiting toxicities reported in the 28-days following dosing - Phase 1/2 redePHine study (NCT06839235) dose escalation ongoing with enrollment at Mayo Clinic in the US and plans to open …

New York Academy of Medicine Welcomes Three Visionary Leaders to Its Board of Trustees

New York Academy of Medicine Welcomes Three Visionary Leaders to Its Board of Trustees

New York, NY, July 30, 2025 (GLOBE NEWSWIRE) -- New York Academy of Medicine (NYAM) has appointed three nationally recognized health leaders to its Board of Trustees, reinforcing its commitment to healthier, longer lives for everyone: Debra Albert, DNP, …

Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin

Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin

– New patent enhances market position in Europe HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard- …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions